Source: Brown A, et al. EASL 2015; Abstract P0771.Elbasvir + Grazoprevir +/- RBV in Treatment-Naïve GT 2, 4, 5 or 6C-SCAPE Study: Study Design for GT 1EBR-GZR + RBVGT 2Non-cirrhoticn = 30EBR-GZR + RBVEBR-GZRGZR + RBVGT 4, 5, or 6Non-cirrhoticn = 30n = 19n = 19Week012Abbreviations: EBR = Elbasvir; GZR = Grazoprevir; RBV = ribavirinDrug DosingElbasvir (50 mg) once dailyGrazoprevir (100 mg) once dailyRibavirin (weight-based and divided bid): 800 to 1400 mg/day24SVR12SVR12SVR12SVR12